Delivery across the skin for systemic absorption via patch systems. Includes drug-in- adhesive, matrix, and reservoir patches with integrated IVPT testing, adhesion evaluation, and controlled release optimization.

Optimized Formulations for Nail and Hard Tissue Penetration

At MedPharm, we specialize in ungual drug delivery, focusing on the development of advanced topical formulations designed to penetrate the hard keratin structure of nails. Our solutions are effective for treating onychomycosis, nail psoriasis, and various other nail-related conditions. Our scientifically-driven formulation strategies, penetration enhancement technologies, and in-vitro testing expertise ensure that ungual drug products achieve optimal bioavailability, sustained retention, and enhanced therapeutic efficacy.

With customized excipients, controlled-release mechanisms, and permeability optimization, MedPharm’s ungual drug delivery solutions provide targeted treatment, leading to improved patient compliance and success in meeting regulatory requirements.

Optimized Inhalation and Nasal Formulations for Effective Pulmonary Absorption 

At MedPharm, we specialize in respiratory drug delivery, developing advanced inhalable and nasal formulations designed for precise, efficient, and patient-friendly administration. Our expertise includes liquid sprays, dry powder inhalers (DPIs), and nebulized formulations. We ensure that respiratory drugs achieve optimal lung deposition, rapid onset, and enhanced bioavailability while maintaining regulatory compliance and stability.

Our scientifically driven approach, combined with in-vitro bioequivalence testing, particle size optimization, and GMP-compliant manufacturing, enables the development of high-performance respiratory therapies for conditions such as asthma, COPD, allergic rhinitis, and nasal infections.

Optimized Formulations for Targeted Ear Therapies

At MedPharm, we specialize in otic drug delivery, developing advanced formulations designed for precise, effective, and patient-friendly treatments of ear infections, inflammation, and other auditory conditions. Our expertise in liquid, suspension, and semi-solid otic formulations, combined with cutting-edge permeation enhancement technologies and regulatory-compliant manufacturing, ensures that otic drugs achieve optimal absorption, retention, and therapeutic performance.  

With customized viscosity, pH-balanced formulations, and preservative-free options, MedPharm’s otic drug delivery solutions provide enhanced bioavailability, prolonged drug retention, and improved patient compliance.  

Precision Formulations for Enhanced Ocular Therapeutics 

At MedPharm, our expertise in ophthalmic drug delivery ensures that both topical and transdermal ocular formulations are designed for optimal corneal penetration, sustained drug release, and patient compliance. We specialize in creating sterile, bioavailable, and effective ophthalmic formulations, utilizing advanced drug delivery technologies to maximize therapeutic impact while minimizing systemic exposure.

With a profound understanding of ocular physiology, permeability challenges, and regulatory compliance, we assist pharmaceutical companies in developing ophthalmic solutions tailored for both anterior and posterior eye conditions, ensuring safety, efficacy, and commercial readiness.

Optimized Formulations for Targeted Absorption

At MedPharm, we specialize in mucosal drug delivery by developing advanced formulations for buccal, nasal, vaginal, and rectal applications. With industry-leading formulation expertise, in vitro testing capabilities, and GMP-compliant manufacturing, we ensure targeted absorption, enhanced bioavailability, and patient-friendly administration.  

Our approach integrates mucoadhesive technologies, permeation enhancers, and controlled-release strategies to optimize drug delivery while prioritizing patient safety and regulatory compliance.  

Advancing Formulations for Localized and Systemic GI Therapies

At MedPharm, we specialize in the development of innovative drug products targeting the gastrointestinal (GI) tract, with expertise spanning topical GI treatments to systemic therapies delivered via mucosal absorption. Whether you are formulating for localized conditions or systemic bioavailability through oral mucosal, esophageal, or rectal delivery, our team applies a science-driven approach to maximize therapeutic outcomes.

We understand the unique challenges of delivering drugs to the GI tract—such as variable pH, enzymatic degradation, mucosal barriers, and transit times—and we design our formulations to overcome these complexities with precision and performance.